Aldeyra Therapeutics Announces Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to Aldeyra Therapeutics Announces Third Quarter 2018 Financial Results

Aldeyra Therapeutics (ALDX) Reports Q3 Loss of $0.52

November 14, 2018 7:02 AM EST

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.52), versus ($0.32) reported last year.

"The third quarter was highlighted by positive results from our Phase 2b clinical trial of reproxalap in dry eye disease and an investigator-sponsored Phase 1/2 clinical trial of ADX-1612 in malignant... More